221
Views
3
CrossRef citations to date
0
Altmetric
Letter

Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

, , , , , , , , , , , , & show all
Pages 725-727 | Received 20 Aug 2011, Accepted 27 Aug 2011, Published online: 27 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Prioty Islam, Jordan Goldstein & Christopher R. Flowers. (2019) PET-derived tumor metrics predict DLBCL response and progression-free survival. Leukemia & Lymphoma 60:8, pages 1965-1971.
Read now
Qiushi Chen, Turgay Ayer, Loretta J. Nastoupil, Jean L. Koff, Ashley D. Staton, Jagpreet Chhatwal & Christopher R. Flowers. (2016) Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma. Leukemia & Lymphoma 57:4, pages 842-851.
Read now

Articles from other publishers (1)

Disni Muringampurath‐John, David L. Jaye, Christopher R. Flowers, Debra Saxe, Zhengjia Chen, Mary J. Lechowicz, Dennis D. Weisenburger, Martin Bast, Martha L. Arellano, Leon Bernal‐Mizrachi, Leonard T. Heffner, Morgan McLemore, Jonathan L. Kaufman, Elliott F. Winton, Sagar Lonial, James O. Armitage & Hanna J. Khoury. (2012) Characteristics and outcomes of diffuse large B ‐cell lymphoma presenting in leukaemic phase . British Journal of Haematology 158:5, pages 608-614.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.